7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vision Disorders D014786 10 associated lipids
Multiple Myeloma D009101 13 associated lipids
Osteoporosis D010024 12 associated lipids
Kidney Diseases D007674 29 associated lipids
Weight Gain D015430 101 associated lipids
Otosclerosis D010040 2 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Glioma D005910 112 associated lipids
Calcinosis D002114 5 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Sagar DR et al. Osteoprotegerin reduces the development of pain behaviour and joint pathology in a model of osteoarthritis. 2014 Ann. Rheum. Dis. pmid:23723320
Liu M et al. Curculigoside improves osteogenesis of human amniotic fluid-derived stem cells. 2014 Stem Cells Dev. pmid:24007307
Zhao H et al. Long-term resveratrol treatment prevents ovariectomy-induced osteopenia in rats without hyperplastic effects on the uterus. 2014 Br. J. Nutr. pmid:24073920
Honma M et al. Regulatory mechanisms of RANKL presentation to osteoclast precursors. 2014 Curr Osteoporos Rep pmid:24477414
Lewis JR et al. Elevated osteoprotegerin predicts declining renal function in elderly women: a 10-year prospective cohort study. 2014 Am. J. Nephrol. pmid:24457210
Cao H et al. Preoperative serum receptor activator of nuclear factor-κB ligand/osteoprotegerin predict stabilization of spontaneously restored sinus rhythm in persistent atrial fibrillation patients after mitral valve surgery. 2014 Cardiology pmid:24434592
Miller RE et al. RANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. 2014 J Thorac Oncol pmid:24496001
Lim WH et al. Downregulation of Wnt causes root resorption. 2014 Am J Orthod Dentofacial Orthop pmid:25172256
Ostrowska Z et al. Selected adipose tissue hormones, bone metabolism, osteoprotegerin and receptor activator of nuclear factor-kB ligand in postmenopausal obese women. 2014 Endokrynol Pol pmid:25554611
Shen A et al. Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients. 2014 Medicine (Baltimore) pmid:25546658
MacMillan AK et al. Similar healthy osteoclast and osteoblast activity on nanocrystalline hydroxyapatite and nanoparticles of tri-calcium phosphate compared to natural bone. 2014 Int J Nanomedicine pmid:25506216
Tella SH and Gallagher JC Prevention and treatment of postmenopausal osteoporosis. 2014 J. Steroid Biochem. Mol. Biol. pmid:24176761
Jiang Y et al. Achyranthes bidentata extract exerts osteoprotective effects on steroid-induced osteonecrosis of the femoral head in rats by regulating RANKL/RANK/OPG signaling. 2014 J Transl Med pmid:25471933
Lenglet S et al. Statin treatment is associated with reduction in serum levels of receptor activator of NF-κB ligand and neutrophil activation in patients with severe carotid stenosis. 2014 Mediators Inflamm. pmid:24648660
Takeshita S et al. Age-related marrow adipogenesis is linked to increased expression of RANKL. 2014 J. Biol. Chem. pmid:24753250
Akiyama T et al. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain. 2014 J. Biol. Chem. pmid:24755218
Zhang X et al. Ultrastructural characterization of the implant interface response to loading. 2014 J. Dent. Res. pmid:24389808
Lv Z et al. Bone morphogenetic protein 9 regulates tumor growth of osteosarcoma cells through the Wnt/β-catenin pathway. 2014 Oncol. Rep. pmid:24337584
Cao H et al. Force-induced Adrb2 in periodontal ligament cells promotes tooth movement. 2014 J. Dent. Res. pmid:25252876
Prates TP et al. NOD2 contributes to Porphyromonas gingivalis-induced bone resorption. 2014 J. Dent. Res. pmid:25239844
Yamamoto N et al. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. 2014 Int. J. Mol. Med. pmid:25234201
Olivares-Navarrete R et al. Osteoblast lineage cells can discriminate microscale topographic features on titanium-aluminum-vanadium surfaces. 2014 Ann Biomed Eng pmid:25227453
Giuliani AL et al. Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma. 2014 PLoS ONE pmid:25226385
Köttstorfer J et al. Are OPG and RANKL involved in human fracture healing? 2014 J. Orthop. Res. pmid:25212894
Esteghamati A et al. Serum osteoprotegerin in relation to metabolic status, severity, and estimated risk of subsequent coronary heart disease. 2014 Arch Iran Med pmid:25204474
Jasiewicz M et al. Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. 2014 Pol. Arch. Med. Wewn. pmid:25188298
Liu YD et al. Reducing dietary loading decreases mouse temporomandibular joint degradation induced by anterior crossbite prosthesis. 2014 Osteoarthr. Cartil. pmid:24316289
Genre F et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. 2014 PLoS ONE pmid:25184828
Zhang YD et al. Association of the g.19074G>A genetic variant in the osteoprotegerin gene with bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:25177945
Bandeira F et al. Bone markers and osteoporosis therapy. 2014 Arq Bras Endocrinol Metabol pmid:25166041
Kuroyanagi G et al. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling. 2014 Arch. Biochem. Biophys. pmid:24333336
Jung Koo H et al. Effect of the combinatory mixture of Rubus coreanus Miquel and Astragalus membranaceus Bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect. 2014 J Ethnopharmacol pmid:24333364
Bosman MC et al. Decreased affinity of recombinant human tumor necrosis factor-related apoptosis-inducing ligand (rhTRAIL) D269H/E195R to osteoprotegerin (OPG) overcomes TRAIL resistance mediated by the bone microenvironment. 2014 J. Biol. Chem. pmid:24280212
Kim YH et al. Enhancement of bone regeneration by dual release of a macrophage recruitment agent and platelet-rich plasma from gelatin hydrogels. 2014 Biomaterials pmid:24125774
Klimek E et al. Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration. 2014 Mediators Inflamm. pmid:24864133
Chen H et al. Runx2 regulates endochondral ossification through control of chondrocyte proliferation and differentiation. 2014 J. Bone Miner. Res. pmid:24862038
Li B et al. Periodontal ligament stem cells modulate root resorption of human primary teeth via Runx2 regulating RANKL/OPG system. 2014 Stem Cells Dev. pmid:24827498
Lee SI et al. NOD2 Mediates Odontoblast Differentiation and RANKL Expression. 2014 J. Dent. Res. pmid:24820666
Araújo AA et al. Azilsartan increases levels of IL-10, down-regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and up-regulates OPG in an experimental periodontitis model. 2014 PLoS ONE pmid:24819928
Cianciolo G et al. Importance of vascular calcification in kidney transplant recipients. 2014 Am. J. Nephrol. pmid:24819032
Sänger N et al. OPG and PgR show similar cohort specific effects as prognostic factors in ER positive breast cancer. 2014 Mol Oncol pmid:24785095
Hidayat R et al. Correlation between receptor activator of nuclear factor-κβ ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients. 2014 Acta Med Indones pmid:24760805
Milanova V et al. TLR2 elicits IL-17-mediated RANKL expression, IL-17, and OPG production in neutrophils from arthritic mice. 2014 Mediators Inflamm. pmid:24757287
Jiang XY et al. TNFRSF11B polymorphisms are associated with metabolic traits in Uyghur and Han ethnic groups. 2014 Endocr. Res. pmid:23772656
Nolen BM et al. Prediagnostic serum biomarkers as early detection tools for pancreatic cancer in a large prospective cohort study. 2014 PLoS ONE pmid:24747429
Zhao JJ et al. Association analysis between the OPG g.27667T>A genetic variant and bone mineral density in Chinese postmenopausal women. 2014 Genet. Mol. Res. pmid:24737508
Yoo YM et al. Effects of neuropeptides and mechanical loading on bone cell resorption in vitro. 2014 Int J Mol Sci pmid:24717410
Shao X et al. Metformin rescues the MG63 osteoblasts against the effect of high glucose on proliferation. 2014 J Diabetes Res pmid:24812633
Guo L et al. Effects of erythropoietin on osteoblast proliferation and function. 2014 Clin. Exp. Med. pmid:23135151
Navratilova Z et al. Osteoprotegerin gene polymorphism is not associated with prosthetic joint infection after total joint arthroplasty in the Czech population. 2014 Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub pmid:22660233

Table of Content